Cargando…
Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188300/ https://www.ncbi.nlm.nih.gov/pubmed/37207268 http://dx.doi.org/10.1093/rap/rkad046 |
| _version_ | 1785042883423764480 |
|---|---|
| author | Feng, Jin Meir, Lea Ghaw, Olivia |
| author_facet | Feng, Jin Meir, Lea Ghaw, Olivia |
| author_sort | Feng, Jin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10188300 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101883002023-05-18 Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease Feng, Jin Meir, Lea Ghaw, Olivia Rheumatol Adv Pract Letter to the Editor (Case report) Oxford University Press 2023-05-02 /pmc/articles/PMC10188300/ /pubmed/37207268 http://dx.doi.org/10.1093/rap/rkad046 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor (Case report) Feng, Jin Meir, Lea Ghaw, Olivia Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease |
| title | Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease |
| title_full | Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease |
| title_fullStr | Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease |
| title_full_unstemmed | Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease |
| title_short | Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease |
| title_sort | canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset still’s disease |
| topic | Letter to the Editor (Case report) |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188300/ https://www.ncbi.nlm.nih.gov/pubmed/37207268 http://dx.doi.org/10.1093/rap/rkad046 |
| work_keys_str_mv | AT fengjin canakinumabandmycophenolatemofetilinmanagingproteinuriarenalamyloidosissecondarytoadultonsetstillsdisease AT meirlea canakinumabandmycophenolatemofetilinmanagingproteinuriarenalamyloidosissecondarytoadultonsetstillsdisease AT ghawolivia canakinumabandmycophenolatemofetilinmanagingproteinuriarenalamyloidosissecondarytoadultonsetstillsdisease |